Association studies in Asthma

Genetics of Asthma and Chronic Obstructive Pulmonary Disease

Volumn , Issue , 2006, Pages 239-272

  Laing, Ingrid A ^a,b   Souëf, Peter N Le ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b AUSTRALIAN RESEARCH COUNCIL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882560957     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (189)

1. Palmer LJ. Linkages and associations to intermediate phenotypes underlying Asthma and allergic disease. Curr Opin Allergy Clin Immunol 2001; 1:393-398.
2. Hoffjan S, Nicolae D, Ober C. Association studies for Asthma and atopic diseases: a comprehensive review of the literature. Respir Res 2003; 4:14.
3. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006.
4. Hall IP. Genetics and pulmonary medicine: Asthma. Thorax 1999; 54:65-69.
5. Le Souef PN. Genetics. In: Silverman M, ed. Childhood Asthma and Other Wheezing Disorders. 2nd ed. London: Arnold, 2002:85-92.
6. http://www.ncbi.nlm.nih.gov/SNP/index.html
7. http://innateimmunity.net//
8. Turner SW, Le Souef PN. Is patient dropout from a longitudinal study of lung function predictable and reversible? Pediatr Pulmonol 2003; 35:29-33.
9. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361:598-604.
10. Palmer LJ, Cookson WO. Using single nucleotide polymorphisms as a means to understanding the pathophysiology of Asthma. Respir Res 2001; 2:102-112.
11. Ronckers C, Land C, Hayes R, et al. Factors impacting questionnaire response in a Dutch retrospective cohort study. Ann Epidemiol 2004; 14:66-72.
12. Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156:300-310.
13. Page GP, George V, Go RC, et al. ‘Are we there yet?’ Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet 2003; 73:711-719.
14. Renzoni E, Forastiere F, Biggeri A, et al. Differences in parental-and selfreport of Asthma, rhinitis and eczema among Italian adolescents. SIDRIA collaborative group. Eur Respir J 1999; 14:597-604.
15. Toren K, Brisman J, Jarvholm B. Asthma and Asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993; 104:600-608.
16. Barnes KC. Gene-environment and gene-gene interaction studies in the molecular genetic analysis of Asthma and atopy. Clin Exp Allergy 1999; 29 (Suppl 4):47-51.
17. Aitken L, Gallagher R, Madronio C. Principles of recruitment and retention in clinical trials. Int J Nurs Pract 2003; 9:338-346.
18. Wittke-Thompson JK, Pluzhnikov A, Cox NJ. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 967-986.
19. Venter JC, Levy S, Stockwell T, et al. Massive parallelism, randomness and genomic advances. Nat Genet 2003; 33(suppl):219-227.
20. Amatschek S, Koenig U, Auer H, et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 2004; 64:844-856.
21. Brutsche MH, Joos L, Carlen Brutsche IE, et al. Array-based diagnostic geneexpression score for atopy and Asthma. JAllergy Clin Immunol 2002; 109:271-273.
22. Meyers DA, Postma DS, Stine OC, et al. Genome screen for Asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol 2005; 115:1169-1175.
23. Eder W, Klimecki W, Yu L, et al. Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments. J Allergy Clin Immunol 2005; 116:601-607.
24. Hall IP, Blakey JD. Genetic association studies in Thorax. Thorax 2005; 60:357-359.
25. Palmer LJ, Silverman ES, Weiss ST, et al. Pharmacogenetics of Asthma. Am J Respir Crit Care Med 2002; 165:861-866.
26. Simon Thomas N, Wilkinson J, Lonjou C, et al. Linkage analysis of markers on chromosome 11q13 with Asthma and atopy in a United Kingdom population. Am J Respir Crit Care Med 2000; 162:1268-1272.
27. Blakey J, Halapi E, Bjornsdottir US, et al. Contribution of ADAM33 polymorphisms to the population risk of Asthma. Thorax 2005; 60:274-276.
28. De Marco R, Locatelli F, Cerveri I, et al. Incidence and remission of Asthma: a retrospective study on the natural history of Asthma in Italy. J Allergy Clin Immunol 2002; 110:228-235.
29. Silvestri M, Sabatini F, Defilippi AC, et al. The wheezy infant—immunological and molecular considerations. Paediatr Respir Rev 2004; 5(suppl A):S81-S87.
30. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133-138.
31. Oddy WH, Holt PG, Sly PD, et al. Association between breast feeding and Asthma in 6 year old children: findings of a prospective birth cohort study. Br Med J 1999; 319:815-819.
32. Oddy WH, Peat JK, de Klerk NH. Maternal Asthma, infant feeding, and the risk of Asthma in childhood. J Allergy Clin Immunol 2002; 110:65-67.
33. Wright AL, Holberg CJ, Taussig LM, et al. Factors influencing the relation of infant feeding to Asthma and recurrent wheeze in childhood. Thorax 2001; 56:192-197.
34. Holt PG, Sly PD. Interactions between RSV infection, Asthma, and atopy: unraveling the complexities. J Exp Med 2002; 196:1271-1275.
35. Holt PG, Sly PD. Interactions between respiratory tract infections and atopy in the aetiology of Asthma. Eur Respir J 2002; 19:538-545.
36. Message SD, Johnston SL. Viruses in Asthma. Br Med Bull 2002; 61:29-43.
37. Toren K, Olin AC, Hellgren J, et al. Rhinitis increase the risk for adult-onset Asthma—a Swedish population-based case-control study (MAP-study). Respir Med 2002; 96:635-641.
38. Gautrin D, Newman-Taylor AJ, Nordman H, et al. Controversies in epidemiology of occupational Asthma. Eur Respir J 2003; 22:551-559.
39. Sears MR. Consequences of long-term inflammation. The natural history of Asthma. Clin Chest Med 2000; 21:315-329.
40. Thorn J, Brisman J, Toren K. Adult-onset Asthma is associated with selfreported mold or environmental tobacco smoke exposures in the home. Allergy 2001; 56:287-292.
41. Petsonk EL. Work-related Asthma and implications for the general public. Environ Health Perspect 2002; 110(suppl 4):569-572.
42. O’Donnell AR, Toelle BG, Marks GB, et al. Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am J Respir Crit Care Med 2004; 169:615-622.
43. Kjellman B, Gustafsson PM. Asthma from childhood to adulthood: Asthma severity, allergies, sensitization, living conditions, gender influence and social consequences. Respir Med 2000; 94:454-465.
44. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of Asthma and wheezing illness from early childhood to age 33 in a national British cohort. Br Med J 1996; 312:1195-1199.
45. Horwood LJ, Fergusson DM, Shannon FT. Social and familial factors in the development of early childhood Asthma. Pediatrics 1985; 75:859-868.
46. Abramson M, Kutin JJ, Raven J, et al. Risk factors for Asthma among young adults in Melbourne, Australia. Respirology 1996; 1:291-297.
47. Martin AJ, McLennan LA, Landau LI, et al. The natural history of childhood Asthma to adult life. Br Med J 1980; 280:1397-1400.
48. Sunyer J, Anto JM, Kogevinas M, et al. Risk factors for Asthma in young adults. Spanish Group of the European Community Respiratory Health Survey. Eur Respir J 1997; 10:2490-2494.
49. Tepper RS, Morgan WJ, Cota K, et al. Physiologic growth and development of the lung during the first year of life. Am Rev Respir Dis 1986; 134:513-519.
50. Tepper RS, Reister T. Forced expiratory flows and lung volumes in normal infants. Pediatr Pulmonol 1993; 15:357-361.
51. von Mutius E. Progression of allergy and Asthma through childhood to adolescence. Thorax 1996; 51(suppl 1):S3-S6.
52. Agarwal SK, Marshall GD Jr. Perimenstrual alterations in type-1/type-2 cytokine balance of normal women. Ann Allergy Asthma Immunol 1999; 83: 222-228.
53. Dodge R, Cline MG, Burrows B. Comparisons of Asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. Am Rev Respir Dis 1986; 133:981-986.
54. Amelung PJ, Postma DS, Xu J, et al. Exclusion of chromosome 11q and the FcepsilonRI-beta gene as aetiological factors in allergy and Asthma in a population of Dutch Asthmatic families. Clin Exp Allergy 1998; 28:397-403.
55. Rothman KJ. Modern Epidemiology. Boston: Little Brown, 1986:358.
56. Yin K, Zhang X, Qiu Y. Association between beta(2)-adrenergic receptor genetic polymorphisms and nocturnal Asthmatic patients of Chinese Han Nationality. Respiration 2006; 73:464-467.
57. Qiu YY, Zhang XL, Yin KS. Association between beta(2)-adrenergic receptor genetic polymorphisms and total serum IgE in Asthmatic patients of Chinese Han Nationality. Respiration 2006; 73:180-184.
58. Hirota T, Suzuki Y, Hasegawa K, et al. Functional haplotypes of IL-12B are associated with childhood atopic Asthma. J Allergy Clin Immunol 2005; 116:789-795.
59. Lima JJ, Zhang S, Grant A, et al. Influence of leukotriene pathway polymorphisms on response to Montelukast in Asthma. Am J Respir Crit Care Med 2005.
60. Choi JH, Kim SH, Bae JS, et al. Lack of an association between a newly identified promoter polymorphism (-1702G>A) of the leukotriene C4 synthase gene and aspirin-intolerant Asthma in a Korean population. Tohoku J Exp Med 2006; 208:49-56.
61. Gupta V, Sarin BC, Changotra H, et al. Association of G-308A TNF-alpha polymorphism with bronchial Asthma in a North Indian population. J Asthma 2005; 42:839-841.
62. Oh JM, Kim SH, Suh CH, et al. Lack of association of glutathione S-transferase P1 Ile105Val polymorphism with aspirin-intolerant Asthma. Korean J Intern Med 2005; 20:232-236.
63. Imboden M, Nicod L, Nieters A, et al. The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic Asthma. The SAPALDIA Cohort Study. Clin Exp Allergy 2006; 36:211-218.
64. Liang XH, Cheung W, Heng CK, et al. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun 2005; 338:736-741.
65. Barnes KC, Grant AV, Baltadzhieva D, et al. Variants in the gene encoding C3 are associated with Asthma and related phenotypes among African Caribbean families. Genes Immun 2006; 7:27-35.
66. Mak JC, Leung HC, Ho SP, et al. Analysis of TGF-beta(1) gene polymorphisms in Hong Kong Chinese patients with Asthma. J Allergy Clin Immunol 2006; 117:92-96.
67. Cookson W, Moffatt M. Making sense of Asthma genes. N Engl J Med 2004; 351:1794-1796.
68. Cookson WO. Asthma genetics. Chest 2002; 121:7S-13S.
69. Baldini M, Lohman IC, Halonen M, et al. A Polymorphism_ in the 50 flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-983.
70. Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001; 163:965-969.
71. Leung TF, Tang NL, Sung YM, et al. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003; 14:255-260.
72. Kabesch M, Hasemann K, Schickinger V, et al. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy 2004; 59:520-525.
73. Gao PS, Mao XQ, Baldini M, et al. Serum total IgE levels and CD14 on chromosome 5q31. Clin Genet 1999; 56:164-165.
74. Buckova D, Holla LI, Schuller M, et al. Two CD14 promoter polymorphisms and atopic phenotypes in Czech patients with IgE-mediated allergy. Allergy 2003; 58:1023-1026.
75. Sharma M, Batra J, Mabalirajan U, et al. Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic Asthma in northern and northwestern Indian populations. Immunogenetics 2004; 56: 544-547.
76. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167:5838-5844.
77. Vercelli D, Baldini M, Martinez F. The monocyte/IgE connection: may polymorphisms in the CD14 gene teach us about IgE regulation? Int Arch Allergy Immunol 2001; 124:20-24.
78. Martin AC, Laing IA, Khoo SK, et al. Acute Asthma in children: relationship between CD14 and CC16 genotype, plasma levels and severity. Am J Respir Crit Care Med 2005.
79. Rosenwasser LJ, Klemm DJ, Dresback JK, et al. Promoter polymorphisms in the chromosome 5 gene cluster in Asthma and atopy. Clin Exp Allergy 1995; 25(suppl 2):74-78; discussion 95-96.
80. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77:1859-1870.
81. Kabesch M, Tzotcheva I, Carr D, et al. A complete screening of the IL4 gene: novel polymorphisms and their association with Asthma and IgE in childhood. J Allergy Clin Immunol 2003; 112:893-898.
82. Noguchi E, Shibasaki M, Arinami T, et al. Association of Asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998; 28:449-453.
83. Sandford AJ, Chagani T, Zhu S, et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and Asthma severity. J Allergy Clin Immunol 2000; 106: 135-140.
84. Burchard EG, Silverman EK, Rosenwasser LJ, et al. Association between a sequence variant in the IL-4 gene promoter and FEV(1) in Asthma. Am J Respir Crit Care Med 1999; 160:919-922.
85. Zhu S, Chan-Yeung M, Becker AB, et al. Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med 2000; 161:1655-1659.
86. Beghe B, Barton S, Rorke S, et al. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to Asthma and atopy in a Caucasian population. Clin Exp Allergy 2003; 33:1111-1117.
87. Kammer W, Lischke A, Moriggl R, et al. Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling. J Biol Chem 1996; 271:23634-23637.
88. Wjst M, Kruse S, Illig T, et al. Asthma and IL-4 receptor alpha gene variants. Eur J Immunogenet 2002; 29:263-268.
89. Ober C, Leavitt SA, Tsalenko A, et al. Variation in the interleukin 4-receptor alpha gene confers susceptibility to Asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000; 66:517-526.
90. Wills-Karp M, Chiaramonte M. Interleukin-13 in Asthma. Curr Opin Pulm Med 2003; 9:21-27.
91. Howard TD, Whittaker PA, Zaiman AL, et al. Identification and association of polymorphisms in the interleukin-13 gene with Asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001; 25:377-384.
92. Hummelshoj T, Bodtger U, Datta P, et al. Association between an interleukin-13 promoter polymorphism and atopy. Eur J Immunogenet 2003; 30:355-359.
93. van der Pouw Kraan TC, van Veen A, Boeije LC, et al. An IL-13 promoter polymorphism associated with increased risk of allergic Asthma. Genes Immun 1999; 1:61-65.
94. Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000; 105: 506-513.
95. Heinzmann A, Jerkic SP, Ganter K, et al. Association study of the IL13 variant Arg110Gln in atopic diseases and juvenile idiopathic arthritis. J Allergy Clin Immunol 2003; 112:735-739.
96. Liu X, Nickel R, Beyer K, et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study. J Allergy Clin Immunol 2000; 106:167-170.
97. Wang M, Xing ZM, Lu C, et al. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet 2003; 113:387-390.
98. He JQ, Chan-Yeung M, Becker AB, et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 2003; 4:385-389.
99. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
100. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24:1-8.
101. Lim S, Crawley E, Woo P, et al. Haplotype associated with low interleukin-10 production in patients with severe Asthma. Lancet 1998; 352:113.
102. Papadopoulos NG, Stanciu LA, Papi A, et al. A defective type 1 response to rhinovirus in atopic Asthma. Thorax 2002; 57:328-332.
103. Wills-Karp M. IL-12/IL-13 axis in allergic Asthma. J Allergy Clin Immunol 2001; 107:9-18.
104. Sieburth D, Jabs EW, Warrington JA, et al. Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics 1992; 14:59-62.
105. Morahan G, Huang D, Wu M, et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic Asthma in children. Lancet 2002; 360:455-459.
106. Khoo SK, Hayden CM, Roberts M, et al. Associations of the IL12B promoter polymorphism in longitudinal data from Asthmatic patients 7 to 42 years of age. J Allergy Clin Immunol 2004; 113:475-481.
107. Pene J, Chretien I, Rousset F, et al. Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23). J Cell Biochem 1989; 39:253-264.
108. Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 167:970-975.
109. Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61:863-866.
110. Rossouw M, Nel HJ, Cooke GS, et al. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003; 361:1871-1872.
111. Juliger S, Bongartz M, Luty AJ, et al. Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 2003; 54:675-680.
112. Gao PS, Mao XQ, Jouanguy E, et al. Nonpathogenic common variants of IFNGR1 and IFNGR2 in association with total serum IgE levels. Biochem Biophys Res Commun 1999; 263:425-429.
113. Lien E, Sellati TJ, Yoshimura A, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33,419-33,425.
114. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-376.
115. Michel O, LeVan TD, Stern D, et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol 2003; 112:923-929.
116. Hirschfeld M, Ma Y, Weis JH, et al. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000; 165:618-622.
117. Eder W, Klimecki W, Yu L, et al. Toll-like receptor 2 as a major gene for Asthma in children of European farmers. J Allergy Clin Immunol 2004; 113:482-488.
118. Lorenz E, Mira JP, Cornish KL, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68:6398-6401.
119. Papadopoulos NG, Papi A, Psarras S, et al. Mechanisms of rhinovirus-induced Asthma. Paediatr Respir Rev 2004; 5:255-260.
120. Noguchi E, Nishimura F, Fukai H, et al. An association study of Asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 2004; 34:177-183.
121. Raby BA, Klimecki WT, Laprise C, et al. Polymorphisms in toll-like receptor 4 are not associated with Asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002; 166:1449-1456.
122. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-191.
123. Redington AE, Madden J, Frew AJ, et al. Transforming growth factor-beta 1 in Asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156:642-647.
124. Pulleyn LJ, Newton R, Adcock IM, et al. TGFbeta1 allele association with Asthma severity. Hum Genet 2001; 109:623-627.
125. Silverman ES, Palmer LJ, Subramaniam V, et al. Transforming growth factorbeta1 promoter polymorphism C-509T is associated with Asthma. Am J Respir Crit Care Med 2004; 169:214-219.
126. Hobbs K, Negri J, Klinnert M, et al. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and Asthma. Am J Respir Crit Care Med 1998; 158:1958-1962.
127. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8:93-97.
128. Karjalainen J, Hulkkonen J, Hurme M. IL-1 haplotypes and lung function decline. Thorax 2002; 57:561-562; author reply 562.
129. Karjalainen J, Nieminen MM, Aromaa A, et al. The IL-1beta genotype carries Asthma susceptibility only in men. J Allergy Clin Immunol 2002; 109:514-516.
130. Pessi T, Karjalainen J, Hulkkonen J, et al. A common IL-1 complex haplotype is associated with an increased risk of atopy. J Med Genet 2003; 40:e66.
131. Jansky L, Vybiral S, Pospisilova D, et al. Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology 1995; 62:55-61.
132. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18,138-18,144.
133. Choi JH, Park HS, Oh HB, et al. Leukotriene-related gene polymorphisms in ASA-intolerant Asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004; 114:337-344.
134. Drazen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-Asthma treatment. Nat Genet 1999; 22:168-170.
135. In KH, Asano K, Beier D, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997; 99:1130-1137.
136. Sayers I, Barton S, Rorke S, et al. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and Asthma susceptibility in a Caucasian population. Clin Exp Allergy 2003; 33: 1103-1110.
137. Silverman ES, Du J, De Sanctis GT, et al. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am J Respir Cell Mol Biol 1998; 19:316-323.
138. Hatzelmann A, Schatz M, Ullrich V. Involvement of glutathione peroxidase activity in the stimulation of 5-lipoxygenase activity by glutathione-depleting agents in human polymorphonuclear leukocytes. Eur J Biochem 1989; 180:527-533.
139. Hatzelmann A, Ullrich V. Regulation of 5-lipoxygenase activity by the glutathione status in human polymorphonuclear leukocytes. Eur J Biochem 1987; 169:175-184.
140. Imai H, Narashima K, Arai M, et al. Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase. J Biol Chem 1998; 273:1990-1997.
141. Koshino T, Takano S, Houjo T, et al. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of Asthmatics. Biochem Biophys Res Commun 1998; 247:510-513.
142. Koshino T, Takano S, Kitani S, et al. Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with Asthma. Mol Cell Biol Res Comm 1999; 2:32-35.
143. Maiorino M, Bosello V, Ursini F, et al. Genetic variations of gpx-4 and male infertility in humans. Biol Reprod 2003; 68:1134-1141.
144. Sayers I, Barton S, Rorke S, et al. Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in Asthma. Thorax 2003; 58:417-424.
145. Kawagishi Y, Mita H, Taniguchi M, et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced Asthma. J Allergy Clin Immunol 2002; 109:936-942.
146. Sampson AP, Siddiqui S, Buchanan D, et al. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000; 55(suppl 2):S28-S31.
147. Sanak M, Pierzchalska M, Bazan-Socha S, et al. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant Asthma. Am J Respir Cell Mol Biol 2000; 23:290-296.
148. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced Asthma. Lancet 1997; 350:1599-1600.
149. Van Sambeek R, Stevenson DD, Baldasaro M, et al. 50 flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant Asthma phenotype in the United States. J Allergy Clin Immunol 2000; 106:72-76.
150. Villette S, Kyle JA, Brown KM, et al. A novel single nucleotide polymorphism in the 30 untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis 2002; 29:174-178.
151. Whelan GJ, Blake K, Kissoon N, et al. Effect of montelukast on time-course of exhaled nitric oxide in Asthma: influence of LTC4 synthase A(-444)C polymorphism. Pediatr Pulmonol 2003; 36:413-420.
152. Asano K, Shiomi T, Hasegawa N, et al. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate Asthma. Pharmacogenetics 2002; 12:565-570.
153. Currie GP, Lima JJ, Sylvester JE, et al. Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in Asthma. Br J Clin Pharmacol 2003; 56:422-426.
154. Hui Y, Funk CD. Cysteinyl leukotriene receptors. Biochem Pharmacol 2002; 64:1549-1557.
155. Hui Y, Yang G, Galczenski H, et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 2001; 276:47489-47495.
156. Mastalerz L, Nizankowska E, Sanak M, et al. Clinical and genetic features underlying the response of patients with bronchial Asthma to treatment with a leukotriene receptor antagonist. Eur J Clin Invest 2002; 32:949-955.
157. Thompson MD, van’s Gravesande KS, Galczenski H, et al. A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Pharmacogenetics 2003; 13:641-649.
158. Huh JC, Strickland DH, Jahnsen FL, et al. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental Asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med 2003; 198:19-30.
159. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent Asthma in children aged 2 to 5 years. Pediatrics 2001; 108:E48.
160. Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and Asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339.
161. Samuelsson B, Dahlen SE, Lindgren JA, et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237:1171-1176.
162. Holloway JW, Dunbar PR, Riley GA, et al.Association of beta2-adrenergic receptor polymorphisms with severe Asthma. Clin Exp Allergy 2000; 30:1097-1103.
163. Santillan AA, Camargo CA Jr., Ramirez-Rivera A, et al. Association between beta2-adrenoceptor polymorphisms and Asthma diagnosis among Mexican adults. J Allergy Clin Immunol 2003; 112:1095-1100.
164. Turki J, Pak J, Green SA, et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal Asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95:1635-1641.
165. Tan S, Hall IP, Dewar J, et al. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable Asthmatics. Lancet 1997; 350:995-999.
166. Dewar JC, Wheatley AP, Venn A, et al. Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with Asthma in an adult population. Clin Exp Allergy 1998; 28:442-448.
167. Silverman EK, Kwiatkowski DJ, Sylvia JS, et al. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood Asthma management program. J Allergy Clin Immunol 2003; 112:870-876.
168. Summerhill E, Leavitt SA, Gidley H, et al. beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with Asthma, in the Hutterites. Am J Respir Crit Care Med 2000; 162:599-602.
169. Turner SW, Khoo SK, Laing IA, et al. beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and Asthma in infants and children. Clin Exp Allergy 2004; 34:1043-1048.
170. Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 2000; 55:762-767.
171. Fowler SJ, Dempsey OJ, Sims EJ, et al. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to Asthma severity and beta(2)-receptor genotype. Am J Respir Crit Care Med 2000; 162:1318-1322.
172. Lee DK, Currie GP, Hall IP, et al. The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004; 57:68-75.
173. Wilson NM, Lamprill JR, Mak JC, et al. Symptoms, lung function, and beta2-adrenoceptor polymorphisms in a birth cohort followed for 10 years. Pediatr Pulmonol 2004; 38:75-81.
174. Choudhry S, Ung N, Avila PC, et al. Pharmacogenetic differences in response to Albuterol between Puerto Rican and Mexican Asthmatics. Am J Respir Crit Care Med 2005; 171:563-570.
175. Ramsay CE, Hayden CM, Tiller KJ, et al. Association of polymorphisms in the beta2-adrenoreceptor gene with higher levels of parasitic infection. Hum Genet 1999; 104:269-274.
176. Hall IP, Wheatley A, Wilding P, et al. Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in Asthmatic subjects. Lancet 1995; 345:1213-1214.
177. Dewar J, Wheatley A, Wilkinson J, et al. Association of the Gln 27 beta 2-adrenoceptor polymorphism and IgE variability in Asthmatic families. Chest 1997; 111:78S-79S.
178. Dewar JC, Wilkinson J, Wheatley A, et al. The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in Asthmatic families. J Allergy Clin Immunol 1997; 100:261-265.
179. Hopes E, McDougall C, Christie G, et al. Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood Asthma: population based study. Br Med J 1998; 316:664.
180. Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97:10,483-10,488.
181. Van Vyve T, Chanez P, Bernard A, et al. Protein content in bronchoalveolar lavage fluid of patients with Asthma and control subjects. J Allergy Clin Immunol 1995; 95:60-68.
182. Laing IA, Goldblatt J, Eber E, et al. A polymorphism of the CC16 gene is associated with an increased risk of Asthma. J Med Genet 1998; 35:463-467.
183. Laing IA, Hermans C, Bernard A, et al. Association between plasma CC16 levels, the A38G polymorphism, and Asthma. Am J Respir Crit Care Med 2000; 161:124-127.
184. Primakoff P, Myles DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 2000; 16:83-87.
185. Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with Asthma and bronchial hyperresponsiveness. Nature 2002; 418:426-430.
186. Howard TD, Postma DS, Jongepier H, et al. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with Asthma in ethnically diverse populations. J Allergy Clin Immunol 2003; 112:717-722.
187. Werner M, Herbon N, Gohlke H, et al. Asthma is associated with singlenucleotide polymorphisms in ADAM33. Clin Exp Allergy 2004; 34:26-31.
188. Lind DL, Choudhry S, Ung N, et al. ADAM33 is not associated with Asthma in Puerto Rican or Mexican populations. Am J Respir Crit Care Med 2003; 168: 1312-1316.
189. Jongepier H, Boezen HM, Dijkstra A, et al. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in Asthma. Clin Exp Allergy 2004; 34:757-760.